Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysis. - Pontolillo L; Davis AA; Gerratana L; Medford AJ; Wang J; Nicolo' E; Clifton K; Velimirovic M; Warrior S; Podany E; Andreopoulou E; Serafini MS; et al. (NPJ breast cancer, 2025)